[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100500007":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":30,"centralContacts":34,"locations":43,"responsibleParty":60,"collaborators":62,"id":66,"slug":67,"hasResults":68,"nctId":69,"briefTitle":70,"officialTitle":71,"acronym":22,"eligibilityCriteria":72,"healthyVolunteers":73,"sex":74,"minAge":75,"maxAge":76,"enrollmentInfo":77,"targetDuration":25,"studyType":80,"phases":81,"briefSummary":83,"conditions":84,"keywords":86,"overallStatus":45,"whyStopped":25,"lastUpdateSubmitDate":94,"lastUpdatePostDateStruct":95,"startDateStruct":98,"completionDateStruct":100,"leadSponsor":102,"locationsCount":103},{"fullName":5,"class":6},"Generation Next Fertility","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"oPRP injections","EXPERIMENTAL","Patients own prepared PRP will be injected into each ovary",[13],"Other: oPRP",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo","PLACEBO_COMPARATOR","Patient's serum will be injected into the ovary (not rich with platelets)",[19],"Other: Placebo- Serum",[21,26],{"type":6,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"oPRP","Prepared sample from patient's own blood collected and processed. Either PRP or serum is injected into the patient's ovary. All other care is standard for the IVF process",[9],null,{"type":6,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"Placebo- Serum","Patient's serum is injected into ovary instead of PRP as placebo",[15],[31],{"name":32,"affiliation":5,"role":33},"Jesse Hade, MD","PRINCIPAL_INVESTIGATOR",[35,40],{"name":36,"role":37,"phone":38,"phoneExt":25,"email":39},"Alicia Broussard, PhD","CONTACT","3174456958","a.broussard@generationnextfertility.com",{"name":32,"role":37,"phone":41,"phoneExt":25,"email":42},"2126410906","j.hade@generationnextfertility.com",[44],{"facility":5,"status":45,"city":46,"state":46,"zip":47,"country":48,"countryCode":49,"cosmosGeoPoint":50,"geoPoint":55,"contacts":56},"RECRUITING","New York","10022","United States","US",{"type":51,"coordinates":52},"Point",[53,54],-74.00597,40.71427,{"lat":54,"lon":53},[57,59],{"name":32,"role":37,"phone":58,"phoneExt":25,"email":42},"212-641-0906",{"name":36,"role":37,"phone":41,"phoneExt":25,"email":39},{"type":61,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR",[63],{"name":64,"class":65},"Igenomix","INDUSTRY","100500007","ovarian-prp-for-diminished-ovarian-reserve-100500007",false,"NCT05790655","Ovarian PRP for Diminished Ovarian Reserve","Ovarian Platelet-Rich Plasma Injections for Diminished Ovarian Reserve Patients: A Double-Blinded Placebo-Control Trial","Inclusion Criteria:\n\n* Clinical diagnosis of diminished ovarian reserve\n* Clinical diagnosis of poor ovarian response\n* Women age 35-42\n\nExclusion Criteria:\n\n* Clinical diagnosis of premature ovarian failure\n* Clinical diagnosis of menopause.\n* Under 35 years of age\n* Over 42 years of age",true,"FEMALE","35 Years","42 Years",{"count":78,"type":79},230,"ESTIMATED","INTERVENTIONAL",[82],"NA","This prospective double-blinded randomized placebo control study aims to determine if In Vitro Fertilization (IVF) outcomes are improved by ovarian platelet-rich plasma injections (oPRP) for women diagnosed with diminished ovarian reserve (DOR). Women with DOR notoriously have the lowest chance of pregnancy and live birth compared to age-matched peers with a normal or robust ovarian reserve.",[85],"Diminished Ovarian Reserve",[87,88,89,90,91,92,93],"Ovarian Platelet Rich Plasma","DOR","Ovarian PRP","IVF","PRP","PGT-A","ICSI","2025-02-11",{"date":96,"type":97},"2025-02-13","ACTUAL",{"date":99,"type":97},"2023-10-07",{"date":101,"type":79},"2025-12-31",{"name":5,"class":6},1]